A. Hosokawa et al., Facilitation and inhibition by endothelin-1 of adrenal catecholamine secretion in anesthetized dogs, EUR J PHARM, 397(1), 2000, pp. 55-61
We examined the participation of endothelin ETA and ETB receptors in modula
tion by endothelin-1 of adrenal catecholamine secretion during cholinergic
activation in pentobarbital-anesthetized dogs. Drugs were infused intra-art
erially into the adrenal gland. Splanchnic nerve stimulation (1 and 3 Hz) i
ncreased adrenal catecholamine output in a frequency-dependent manner. Endo
thelin-1 (0.2, 0.6, and 2 ng/kg/min) enhanced the catecholamine response in
duced by the 3-Hz nerve stimulation. Under pretreatment with an endothelin
ETA receptor antagonist (R)-2-[( R)-2-[(S)-2-[[1-(hexahydro-1H-azepinyl)]ca
rbonyl]amino-4-methylpentolyl]amino-3-(2-pyridyl) propionic acid (FR139317)
(1 mu g/kg/min), endothelin-1 suppressed the 1- and 3- Hz nerve stimulatio
n-induced catecholamine response in a dose-dependent manner. No inhibitory
or facilitatory effect of endothelin-1 was observed under simultaneous pret
reatment with FR139317 and an endothelin ETB receptor antagonist N-cis 2,6-
dimethylpiperidinocarbonyl-L-gamma-methylleucyl-D-1-methoxy- carbonyltrypto
phanyl-D-norleucine (BQ-788) (1 mu g/kg/min) or under pretreatment with BQ-
788 alone. These results suggest that in the dog adrenal gland, endothelin-
1 facilitates and inhibits adrenal catecholamine secretion during cholinerg
ic activation by stimulating endothelin ETA and ETB receptors, respectively
. (C) 2000 Elsevier Science B.V. All rights reserved.